Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 6, 2005, Pages 591-596

  Fukuda, T ^a,c   Yukawa, E ^b   Kondo, G ^a   Maeda, T ^a   Shin O, T ^a   Kondo, Y ^a   Imamura, T ^c   Irikura, M ^c   Irie, Tetsumi ^c  

^a KUMAMOTO CITY HOSPITAL   (Japan)

^b DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Apnoea; NONMEM; Population analysis; Premature infants; Theophylline

Indexed keywords

AMINOPHYLLINE; DIPROPHYLLINE; THEOPHYLLINE; BRONCHODILATING AGENT;

ARTICLE; BODY WEIGHT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; NEWBORN APNEA; OXYGEN THERAPY; PHARMACOKINETICS; POPULATION MODEL; POPULATION PHARMACOKINETICS; POPULATION RESEARCH; PREMATURITY; APNEA; ASIAN; BIOLOGICAL MODEL; BLOOD; METABOLISM; NEWBORN; REPRODUCIBILITY; RETROSPECTIVE STUDY;

APNEA; ASIAN CONTINENTAL ANCESTRY GROUP; BRONCHODILATOR AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; THEOPHYLLINE;

EID: 33644989545     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00689.x     Document Type: Article

References (16)

1. Alden ER, Mandelkorm T, Woodrum DE, Wennberg RP, Parks CR, Hodson WA (1972) Morbidity and mortality of infants weighing less than 1000 grams in an intensive care nursery. Pediatrics, 50, 40 49.
2. Rigatto H (1982) Apnea. Pediatric Clinics of North America, 29, 1105 1116.
3. Kattwinkel J (1977) Neonatal apnea: pathogenesis and therapy. Journal of Pediatrics, 90, 342 347.
4. Banagale RC, Roloff DW, Howatt WF (1984) Apnea in newborn infants: approach to management. Resuscitation, 11, 9 20.
5. Bhatia J (2000) Current options in the management of apnea of prematurity. Clinical Pediatrics, 39, 327 336.
6. Grisemer AN (1990) Apnea of prematurity: current management and nursing implications. Pediatric Nursing, 16, 606 611.
7. Brouard C, Moriette G, Murat I et al. (1985) Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants. American Journal of Diseases of Children, 139, 698 700.
8. Moore ES, Faix RG, Banagale RC, Grasela TH (1989) The population pharmacokinetics of thephylline in neonates and young infants. Journal of Pharmacokinetics and Biopharmaceutics, 17, 47 66.
9. Lee TC, Charles BG, Steer PA, Flenady VJ, Grant TC (1996) Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea. British Journal of Clinical Pharmacology, 41, 191 200.
10. Karlsson MO, Thomson AH, Mcgovern EM, Chow P, Evans TJ, Kelman AW (1991) Population pharmacokinetics of rectal theophylline in neonates. Therapeutic Drug Monitoring, 13, 195 200.
11. du Preez MJ, Botha JH, McFadyen ML, Holford NHG (1999) The pharmacokinetics of theophylline in premature neonates during the first few days after birth. Therapeutic Drug Monitoring, 21, 598 603.
12. Beal SL, Sheiner LB (eds) (1992) NONMEM user's guides. San Francisco : NONMEM Project Group, University of California at San Francisco.
13. Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmaceutics, 9, 503 512.
14. Neese AL, Soyka LF (1977) Development of a radioimmunoassay for theophylline. Application to studies in premature infants. Clinical Pharmacology and Therapeutics, 21, 633 636.
15. Lantini R, Assael BM, Bonati M et al. (1978) Kinetics and efficacy of thephylline in the treatment of apnea in the premature newborn. European Journal of Clinical Pharmacology, 13, 203 207.
16. Hilligoss DM, Jusko WJ, Koup JR, Giacoia G (1980) Factors affecting theophylline pharmacokinetics in premature infants with apnea. Developmental Pharmacology and Therapeutics, 1, 6 15.